endometriosis
FDA Approves Relugolix for Endometriosis Pain
The FDA relugolix as a once-daily therapy for the management of moderate to severe pain associated with ...
SEPTEMBER 1, 2022
FDA Approves Orilissa for Severe Endometriosis
Orilissa is the first and only oral gonadotropin-releasing hormone antagonist specifically developed to treat women ...
JULY 26, 2018
Load more